Belvedere Trading’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,051	Closed	-$30.6K	–	520
2023 Q3	$30.6K	Buy	+2,051	New	+$30.6K	﹤0.01%	120
2023 Q1	–	Sell	-4,695	Closed	-$29.4K	–	708
2022 Q4	$29.4K	Buy	+4,695	New	+$29.4K	﹤0.01%	235